BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7446536)

  • 1. Comparative bioavailability of two uncoated aminophylline tablets.
    Kwok F; Kradjan WA; Lakshminarayan S; Delaney C
    Am J Hosp Pharm; 1980 Dec; 37(12):1618, 1620. PubMed ID: 7446536
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline levels in patients receiving a controlled-release aminophylline preparation (Phyllocontin Continus tablets).
    Friend JA
    J Int Med Res; 1979; 7 Suppl 1():67-9. PubMed ID: 437310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative serum theophylline levels following the oral administration of elixophyllin and somophyllino-O, a new preparation of aminophylline.
    Sherter C; Denefrio J
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):239-42. PubMed ID: 4206731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absorption of theophylline from an aminophylline mixture].
    Pedersen SE; Helles A
    Ugeskr Laeger; 1983 Mar; 145(11):818-20. PubMed ID: 6857782
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disposition of theophylline in healthy non-smoker volunteers after a single oral dose of aminophylline].
    Prat G; Gazitúa R; Arriagada D; Montero J; Serrat H; Ruiz M; Leiva P
    Rev Med Chil; 1986 Dec; 114(12):1164-7. PubMed ID: 3602698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood theophylline in patients treated with intravenous aminophylline].
    Curull V; Ruiz I; Ferrer J; Pou L; Morell F
    Med Clin (Barc); 1986 Mar; 86(9):363-5. PubMed ID: 3702528
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminophylline bioavailability and the across-time stability of plasma theophylline levels.
    Loren M; Miklich DR; Chai H; Barwise G
    J Pediatr; 1977 Mar; 90(3):473-6. PubMed ID: 839342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of human absorption of theophylline and aminophylline in oral and other administration].
    Scarpa R; Cima L
    Clin Ter; 1969 Aug; 50(4):301-22. PubMed ID: 5382207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
    Tulain U; Ur-Rahman N
    Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theophylline serum levels and theophylline clearance in asthmatic patients (author's transl)].
    Pastor MC; Sabaté I; Torres JM; Corominas M; Fortuny M; Planells P
    Med Clin (Barc); 1982 Jul 1-31; 79(3):126-8. PubMed ID: 7109768
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of theophylline bioavailability from single doses of an elixir and two multi-ingredient tablets.
    Dumas WB; Murphy JE; Shleifer NH; Shah VR
    Clin Pharm; 1982; 1(4):368-70. PubMed ID: 7185533
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of theophylline in asthmatic children after multiple oral doses of aminophylline tablets.
    Hasegawa T; Ogura Y; Takeshi K; Mizukami Y
    Arerugi; 1984 Jun; 33(6):303-7. PubMed ID: 6497661
    [No Abstract]   [Full Text] [Related]  

  • 15. Single dose cross-over theophylline bioavailability study.
    Walker SE; Paton TW; Iazzetta J
    Br J Clin Pract; 1983 Jan; 37(1):23-7. PubMed ID: 6838753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmaceutical and biological availability of theophylline from suppositories with or without aminophylline and with the addition of aerosil].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(2):253-7. PubMed ID: 6097098
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary evaluation of the correlation between in vitro release and in vivo bioavailability of two aminophylline slow-release tablets.
    Lin SY; Kao YH; Chang HN
    J Pharm Sci; 1990 Apr; 79(4):326-30. PubMed ID: 2352144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability of aminophylline tablet and suppository (author's transl)].
    Yoshioka E; Kondo R; Kubo H; Moriguchi I; Suguro N
    Yakugaku Zasshi; 1979 Sep; 99(9):895-900. PubMed ID: 547051
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential pharmacokinetic interaction between theophylline and prednisone.
    Anderson JL; Ayres JW; Hall CA
    Clin Pharm; 1984; 3(2):187-9. PubMed ID: 6723226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.